Partnerships
IMU Powers Drug Discovery & Clinical Breakthroughs
IMU® collaborates with clinical research groups, pharmaceutical, biotech and diagnostics companies to identify and deploy clinically actionable immune signatures that advance precision medicine.
Partnering with IMU
01
Decode Disease Biology
- Discovery of novel immune signatures of disease
- Discovery of mechanistic insights into treatment success, resistance and toxicity
- Identification of new therapeutic targets and immune-driven pathways
- Identification of biomarkers for early diagnosis and disease endotyping
02
Optimise Clinical Development
- Prediction of likely responders and non-responders
- Enablement of patient stratification and selection to improve trial outcomes
- Identification of biomarkers for study design and endpoint selection
- Prediction and monitoring of immune-related adverse events
03
Advance Precision Medicine
- Development of biomarker-driven diagnostics
- Improved donor selection for transplantationÂ
- Personalised drug selection, drug titration and patient monitoring
- Delivery of companion diagnostics for clinical implementation
